LDS/Medical Tests/Tropical Fever Pathogen Panel, Molecular

Tropical Fever Pathogen Panel, Molecular

Malaria, chikungunya, dengue fever, and leptospirosis collectively account for hundreds of millions of infections annually across more than 100 countries and remain major causes of morbidity and mortality worldwide. The global burden of these tropical and vector-borne diseases is expected to increase as climate change, urbanization, international travel, and population displacement create conditions favorable for expanded geographic transmission.

The clinical presentation of tropical fever is often non-specific and overlapping, with symptoms such as fever, headache, myalgia, arthralgia, and malaise, making early clinical differentiation challenging. Delays in etiologic diagnosis may result in inappropriate management, progression to severe disease, or missed opportunities for targeted therapy and supportive interventions.

The tropical Fever (TF) Panel is a multiplex real-time PCR assay designed to rapidly identify common vector-borne and zoonotic pathogens directly from whole blood. The panel detects and differentiates Plasmodium species, including Plasmodium falciparum and Plasmodium vivax/ovale, as well as Dengue virus serotypes 1 through 4, Chikungunya virus, and Leptospira species. By enabling simultaneous detection of multiple pathogens with overlapping clinical presentations, this panel supports timely diagnosis and improved clinical decision-making in patients with suspected tropical or travel-associated febrile illness.

  • As an aid in the diagnosis of acute febrile illness associated with suspected tropical, vector-borne, or zoonotic infections, including malaria, dengue fever, chikungunya, and leptospirosis
  • For differential diagnosis in patients with non-specific febrile illness, particularly in the setting of recent travel, exposure risk, or epidemiologic concern, to guide disease management and appropriate clinical intervention

Detection of one or more targets indicates the presence of nucleic acid from the corresponding pathogen and is consistent with active infection in the appropriate clinical context. The assay provides pathogen-specific identification, including differentiation of Plasmodium species and Dengue virus serotypes, to support diagnosis and management.

Not Detected, indicates no nucleic acid from the targeted pathogens was detected. A negative result does not exclude infection, particularly if testing is performed very early or late in the disease course, or if pathogen levels are below the assay’s limit of detection.

Not Detected

Multiplex real-time polymerase chain reaction (PCR) or other validated molecular amplification methods.

Whole blood (EDTA).

Stability

  • Ambient: 3-5 days
  • Refrigerated: 7 days
Serologic testing for Chikungunya virus and Dengue virus antibodies may be useful for assessing immune response or infection stage. Leptospira antibody testing may be considered to complement molecular testing, particularly in later phases of disease.
3-5 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login